MG
PFE icon

Marex Group’s Pfizer PFE Stock Holding History

Marex Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.31M Sell
178,990
-66,078
-27% -$1.73M 0.02% 271
2026
Q1 		$6.88M Buy
245,068
+29,486
+14% +$785K 0.04% 193
2025
Q4 		$5.37M Buy
215,582
+162,393
+305% +$4.1M 0.03% 210
2025
Q3 		$1.36M Sell
53,189
-12,272
-19% -$303K 0.01% 309
2025
Q2 		$1.59M Sell
65,461
-5,212
-7% -$122K 0.01% 252
2025
Q1 		$1.79M Sell
70,673
-33,659
-32% -$881K 0.03% 182
2024
Q4 		$2.77M Buy
104,332
+8,496
+9% +$230K 0.05% 138
2024
Q3 		$2.77M Buy
+95,836
New +$2.8M 0.06% 124
2024
Q1 		– Sell
-39,664
Closed -$1.14M – 630
2023
Q4 		$1.14M Buy
+39,664
New +$1.2M 0.04% 210

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Marex Group's PFE Position: Q2 2026 in Review

Marex Group reduced its Pfizer (PFE) stake by 27% in Q2 2026, selling an estimated $1.73M and leaving 178,990 shares worth $4.31M. The position accounts for 0.02% of the portfolio, ranked #271.

Marex Group first reported a position in PFE in Q4 2023 and has held it in 9 quarters since. The position peaked at $6.88M in Q1 2026. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Marex Group held 178,990 shares of Pfizer worth $4.31M as of Q2 2026.
  • Marex Group sold 66,078 Pfizer shares in Q2 2026, an estimated $1.73M.
  • Pfizer made up 0.02% of Marex Group's portfolio in Q2 2026, its #271 holding.
  • Marex Group first reported a position in Pfizer in Q4 2023 and has held it in 9 quarters since.
  • Marex Group's Pfizer position peaked at $6.88M in Q1 2026.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.